| Identification | Back Directory | [Name]
4-(2-Methylpropoxy)benzenemethanamine acetate (1:1) | [CAS]
955997-89-4 | [Synonyms]
4-Isobutoxybenzylamine acetate
(4-isobutoxyphenyl)methanamine acetate
4-(2-Methylpropoxy)benzenemethanamine acetate
4-(2-Methylpropoxy)benzenemethanamine acetate (1
Benzenemethanamine, 4-(2-methylpropoxy)-, acetate
4-(2-Methylpropoxy)benzenemethanamine acetate (1:1)
Benzenemethanamine, 4-(2-methylpropoxy)-, acetate (1:1)
4-(2-Methylpropoxy)benzenemethanamine acetate (1:1) ISO 9001：2015 REACH | [EINECS(EC#)]
823-358-7 | [Molecular Formula]
C13H21NO3 | [MDL Number]
MFCD31382012 | [MOL File]
955997-89-4.mol | [Molecular Weight]
239.32 |
| Chemical Properties | Back Directory | [storage temp. ]
Inert atmosphere,Room Temperature | [solubility ]
DMSO; Methanol | [form ]
Crystals | [color ]
White | [InChI]
InChI=1S/C11H17NO.C2H4O2/c1-9(2)8-13-11-5-3-10(7-12)4-6-11;1-2(3)4/h3-6,9H,7-8,12H2,1-2H3;1H3,(H,3,4) | [InChIKey]
VPEGFBXWSGBVDN-UHFFFAOYSA-N | [SMILES]
C(=O)(O)C.O(C1C=CC(CN)=CC=1)CC(C)C |
| Hazard Information | Back Directory | [Uses]
4-Isobutoxybenzylamine Acetate is an intermediate in the synthesis of 1,3-Bis(4-isobutoxybenzyl)urea (B448763), an impurity in the preparation of Pimavanserin (P441800), a drug used in the treatment of Parkinson’s disease and psychosis. |
|
|